We evaluated and compared the safety and efficacy of the conjunctival–limbal autograft, amniotic membrane transplantation,
and intraoperative application of mitomycin C in 94 patients undergoing primary pterygium surgery and concluded that conjunctival–limbal
autografting and amniotic membrane methods were more effective and safer than intraoperative mitomycin C.
Dr. Keklickci is an Assistant Professor of Ophthalmology, Dr. Cakmak is an Associate Professor of Ophthalmology, and Dr. Unlu
is a Professor of Ophthalmology in the Department of Ophthalmology at Dicle University Faculty of Medicine, Diyarbakir, Turkey.
Dr. Celik is a Professor of Biostatistics, Department of Biostatistics, Dicle University Faculty of Medicine, Diyarbakir,
Turkey. Dr. Bilek is an Ophthalmologist, Department of Ophtalmology, Reel Medical Center, Diyarbakir, Turkey.
The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer
or provider of services discussed in this article. The authors do not discuss the use of off-label products, which includes
unlabeled, unapproved, or investigative products or devices.
Based on lower complication rate, the authors concluded that conjunctival–limbal autografting and amniotic membrane methods
were more effective and safer than intraoperative mitomycin C.